{
  "ticker": "INCY",
  "company_name": "Incyte Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04205812",
      "title": "Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer",
      "start_date": "2020-09-11",
      "completion_date": "2026-08-28",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT06056895",
      "title": "Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell Carcinoma",
      "start_date": "2023-11-08",
      "completion_date": "2027-04-30",
      "enrollment": 0,
      "sponsor": "University of Washington"
    },
    {
      "nct_id": "NCT06649201",
      "title": "Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Graft Vs Host Disease, Vulvovaginal Signs and Symptoms",
      "start_date": "2024-12-19",
      "completion_date": "2027-02-15",
      "enrollment": 0,
      "sponsor": "Case Comprehensive Cancer Center"
    },
    {
      "nct_id": "NCT05936359",
      "title": "A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Myeloproliferative Neoplasms",
      "start_date": "2023-09-25",
      "completion_date": "2028-02-29",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT06113471",
      "title": "A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "NonSegmental Vitiligo",
      "start_date": "2023-11-27",
      "completion_date": "2027-03-16",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT03342352",
      "title": "Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Head and Neck Cancer",
      "start_date": "2017-12-15",
      "completion_date": "2018-04-20",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT03616964",
      "title": "A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Systemic Lupus Erythematosus",
      "start_date": "2018-08-02",
      "completion_date": "2021-10-20",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    },
    {
      "nct_id": "NCT01702064",
      "title": "Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Chronic Phase Chronic Myeloid Leukemia",
      "start_date": "2013-02-21",
      "completion_date": "2019-01-09",
      "enrollment": 0,
      "sponsor": "H. Lee Moffitt Cancer Center and Research Institute"
    },
    {
      "nct_id": "NCT06388564",
      "title": "A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Chronic Graft-versus-host-disease",
      "start_date": "2024-10-11",
      "completion_date": "2029-12-01",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT02119676",
      "title": "Study of Ruxolitinib in Colorectal Cancer Patients",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "CRC (Colorectal Cancer)",
      "start_date": "2014-03",
      "completion_date": "2016-12",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE3": 10,
      "PHASE2": 20,
      "": 1,
      "PHASE1": 12,
      "PHASE1, PHASE2": 7
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 11,
      "RECRUITING": 10,
      "WITHDRAWN": 5,
      "COMPLETED": 15,
      "TERMINATED": 9
    },
    "active_trials": 21,
    "completed_trials": 15,
    "conditions": [
      "Acute Lymphoblastic Leukemia",
      "Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm",
      "Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8",
      "Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies",
      "Advanced and/or Metastatic Solid Tumors, Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer, Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma",
      "Advanced or Metastatic Solid Tumors, FGFR Mutations, FGFR Translocations",
      "Atopic Dermatitis",
      "B-Cell Malignancies",
      "Breast Cancer",
      "COVID-19",
      "CRC (Colorectal Cancer)",
      "Chronic Graft Versus Host Disease",
      "Chronic Graft-versus-host-disease",
      "Chronic Phase Chronic Myeloid Leukemia",
      "Chronic Phase Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase",
      "Diabetic Kidney Disease",
      "Follicular Lymphoma, Marginal Zone Lymphoma",
      "Glioblastoma, Brain Cancer, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain, Glioblastoma Multiforme, Adult, MGMT-Unmethylated Glioblastoma, MGMT-Methylated Glioblastoma",
      "Graft Vs Host Disease, Vulvovaginal Signs and Symptoms",
      "Graft-versus-host Disease (GVHD)",
      "Head and Neck Cancer",
      "Healthy Volunteers",
      "Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm",
      "Hemophagocytic Lymphohistiocytoses",
      "Hemophagocytic Lymphohistiocytosis",
      "Immune Thrombocytopenia",
      "Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma",
      "Leukemia, Acute, Myelodysplastic Syndromes, Myelomonocytic Leukemia, Chronic, T-cell Prolymphocytic Leukemia, CML, Myeloproliferative Disorders, Multiple Myeloma, Plasma Cell Leukemia",
      "Lung Cancer",
      "Lymphoma",
      "MPN (Myeloproliferative Neoplasms)",
      "Metastatic Head and Neck Squamous Cell Carcinoma, Advanced Malignancies, Recurrent Head and Neck Squamous Cell Carcinoma",
      "Metastatic Merkel Cell Carcinoma",
      "Metastatic Non-small Cell Lung Cancer, Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer, Unresectable Melanoma, Metastatic Melanoma, Locally Advanced Renal Cell Carcinoma, Metastatic Clear-Cell Renal Cell Carcinoma",
      "Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer",
      "Myelodysplastic Syndromes",
      "Myeloproliferative Neoplasms",
      "Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma",
      "NonSegmental Vitiligo",
      "Rheumatoid Arthritis",
      "Solid Tumor",
      "Solid Tumors",
      "Solid Tumors and Hematologic Malignancy",
      "Solid Tumors and Hematologic Malignancy, NSCLC (Non-small Cell Lung Carcinoma)",
      "Systemic Lupus Erythematosus",
      "Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell Carcinoma"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-05T17:58:08.660102",
    "search_query": "Incyte Corporation",
    "url": "https://clinicaltrials.gov/search?term=Incyte+Corporation"
  }
}